Select your country

North & South America

North & South America

Canada
EN | FR
Colombia

Local distributor

Colombia

Sistemas Medicos, LTDA.

Apartado Aereo 24456
Calle 58 No. 35A61
Bogota
(Colombia)

ph. +571-221-9837
Fax +571-222-5310
Perù

Local distributor

Perù

REIMED, SCRL

Pasaje Villaran 192-194 U-12
Urb. Los Sauces Surquillo
Lima 15076
(Peru)

ph. 511-448-1087
Fax 511-448-3447
Uruguay

Local distributor

Uruguay

Lifenir S.A.

Justicia 2069
C 11800 Montevideo
(Uruguay)

ph. +5982-400-3020
Fax +5982-4007320
Venezuela

Local distributor

Venezuela

SUFOMECA

Torre Polar Oeste
Plaza Venezuela
Floor 7, Room 7C
Caracas
PO Box 1050
(Venezuela)

ph. +582-12-793-3222
Fax +582-12-781-1923

Europe

Europa

Albania

Local distributor

Albania

RX PHARMA Sh.P.K.

Rr Komuna e Parisit
Pallatet Kike - Kulla 2
Tirana
(Albania)

ph. +355 42251091
Bosnia-Herzegowina

Local distributor

Bosnia-Herzegowina

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Bulgaria

Local distributor

Bulgaria

EWOPHARMA AG

73 Persenk Street
App. 27 - Floor 8
1164 Sofia
(Bulgaria)

ph. +359 29624478
Fax +359 28683968
Croatia

Local distributor

Croatia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Greece

Local distributor

Greece

LERIVA IMAGING S.A.

33 Pigis Avenue &
6 Anapiron Polemou Street
151 27 Melissia
Athens (Greece)

ph. +30 210-6199886
Fax +30 210 61 78 733
Kosovo

Local distributor

Kosovo

RX PHARMA Sh.P.K.

Rr Komuna e Parisit
Pallatet Kike - Kulla 2
Tirana
(Albania)

ph. +355 42251091
Montenegro

Local distributor

Montenegro

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Romania

Local distributor

Romania

EWOPHARMA A.G. ROMANIA

B-dul Primaverii 19 -21
Sc. B - Et.1 - Sect. 1
011972 - Bucharest
(Romania)

ph. +40 212601344
Fax +40 212029327
Serbia

Local distributor

Serbia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Slovenia

Local distributor

Slovenia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Hungary

Local distributor

Ungheria

EWOPHARMA REPRESENTATION OFFICE

Budakeszi ut 73/F
H-1021 Budapest
(Hungary)

ph. +36 12004650
Fax +36 13980316

Eastern Europe, Middle East & Africa

Eastern Europe, Middle East & Africa

Ethiopia

Local distributor

Ethiopia

Caroga Pharma PVT. Ltd

P.O.Box 12627
Addis Abeba
(Ethiopia)

ph. +251 11 4654944 / 11 4161090
Fax +251 11 4654595
Ghana

Local distributor

Ghana

Cyndex Pharmacy

P.O.Box DS 1165 Dansoman
Accra
(Ghana)

ph. +233 21553370
Fax +233-244366622 / 21850072
Israel

Local distributor

Israel

DEXCEL

Or-Akiva 30600
30600000 Israel
(Israel)

ph. +972-4-6364015
Fax +972-4-6364004
Jordan

Local distributor

Jordan

THE ARAB DRUG STORE

Khaleel Al Salem street
Amman
(Jordan)

ph. +962 6 5502995
Fax +962 6 5502984
Kenya

Local distributor

Kenya

Nairobi X-Rays Supplies Ltd.

P.O. Box 41669
Nairobi
(Kenya)

ph. +254 20446265-6-7-8
Fax +254 20 4448515/17
Lebanon

Local distributor

Lebanon

Unione Pharmaceutic. d'Orient

Rue du Musée Imm. Stephan QtrBadaro
Beyrouth
(Lebanon)

ph. +961 1 396085-6
Fax +961 1 396047
Mauritius

Local distributor

Mauritius

The Mauritius Pharmacy

4, Louis Pasteur Str Forest Side
(Mauritius)

ph. +230 6762435
Fax +230 675 1387
Saudi Arabia

Local distributor

Saudi Arabia

SARABEEL COMMERCIAL EST.

Medical Division
P.O. BOX 14795
21434 Jeddah
(Saudi Arabia)

ph. +966 12657 2246

Yousef Ahmed Algosaibi Trading Est.

Seventh Floor Sesmo Building
Dhahran Street
(PO Box 5540)
31432 Dammam
(Saudi Arabia)

ph. +966 382 69 490
Fax +966 382 72 528
South Africa

Local distributor

South Africa

AXIM - Head Office Midrand

121 Gazelle Avenue
Corporate Park South
Midrand Johannesburg 2000
(South Africa)

ph. +27 113140140
Fax +27 113140141
Uganda

Local distributor

Uganda

Kampala X-Rays Suppliers

Plot 181 Bombo Rd (KuBbiri)
P.O. Box 9519
Kampala
(Uganda)

ph. +256 41 534313
Fax +256 41 349919
Ukraine

Local distributor

Ukraine

DELTA MEDlCAL

43 Chernovola
Vishnevoe - 08132
(Ukraine)

ph. +38 445933355

Asia Pacific

Asia Pacific

Australia

Local distributor

Australia

REGIONAL HEALTH CARE GROUP

3-11 Primrose Avenue Rosebery
NSW 2018 - Sydney
(Australia)

ph. +61 296624144
Fax +61 296626040
India

Local distributor

India

Imaging Products (India ) Ltd

Mumbai
(India)

ph. +91 9819725471
Fax +91 2228320208
Indonesia

Local distributor

Indonesia

PT DIPA PHARMALAB INTERSAINS

Jl. Panjang No. 10
Kebon Jeruk
Jakarta 11530
(Indonesia)

ph.  +62 215348644
Fax +62 2153676066
New Zealand

Local distributor

New Zealand

REGIONAL HEALTH LIMITED

19C Orbit Drive
Mairangi Bay
(New Zealand)

ph. +64 94140040
Fax +64 94140041
Pakistan

Local distributor

Pakistan

S. EJAZUDDIN & CO LTD

PO Box 5629 - Zia Plaza
Altaf Hussain Road
74000 Karachi
(Pakistan)

ph. +92 21212032
Fax +92 212629716
Philippines

Local distributor

Philippines

NEW MARKETLINK INTERNATIONAL CORP

Tao Corporate Centre 2291
Don Chino Roches Ave
Ext Makati City Metro
Manila (Philippines)

ph. (632) 836-5838
Singapore

Local distributor

Singapore

LF ASIA PHARMACEUTICAL DIVISION

Healthcare Distribution Centre
24 Penjuru Road (off Penjuru Close)
#03-04 CWT Commodity Hub
(Singapore 609128)

ph. +65 65097629
Taiwan

Local distributor

Taiwan

SUPER FORTUNE ENTERPRISE CO LTD

5 F-1 - 42 Sec.1 Ming
Sheng E. Road Jehovah Building
101 Taipei
(Taiwan)

ph. +886 225673456
Fax +886 225319231
Thailand

Local distributor

Thailand

Interpharmacare Co., Ltd.

90 Moo 13 Soi Mahacha
Bangpleeyai
Bangplee
Samutprakarn 10540
(Thailand)

ph. + 66 2 675 9140-2
Fax + 66 2 325 0265
Vietnam

Local distributor

Vietnam

HOANG GIA INVESCO, JSC

No 74-76 Hoa Bang Str
Cau Giay
Dist Ha Noi Hanoi
(Viet Nam)

ph. +43 7846952

Reimbursement

Disclaimers
The information provided below is general reimbursement information for LUMASON®. It is not legal advice, nor is it advice about how to code, complete or submit any particular claim for payment. Although we supply this information based on our current knowledge, it is always the provider’s responsibility to determine and submit appropriate codes, charges, modifiers and bills for services that were rendered. This coding and reimbursement information is subject to change without notice.
Payers or their local branches may have their own coding and reimbursement requirements and policies. Before filing any claims, providers should verify current requirements and policies with the payer.

CPT® copyright 2015 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

2016 REIMBURSEMENT INFORMATION: Echocardiography

Medicare Coding and Payment Overview:

Echocardiography1 with LUMASON®.

National Reimbursement Rates Shown

Procedure Setting

Reimbursement Policy

Codes

2016 National Average Reimbursement rates:

HOPPS (Hospital Outpatient Setting)

Medicare packages payment for contrast imaging agents into the payment for the associated procedure2

C89293
Other HCPCS codes exist depending on the type of study completed

$670.963

HOPPS Transitional Pass Through Code for LUMASON Only

Temporary additional HOPPS payment for innovative medical devices, drugs and biological for Medicare beneficiaries4. It is not subject to coinsurance or packaging rules.

Q99505

Updated quarterly based on Average Sales Price (ASP) + 6%5,6

Five mL per vial1

Hospital In-patient

Part of MS-DRG payment7

ICD-10-PCS8

No separate reimbursement for contrast agents7

Physician Office and Free Standing Imaging Centers

Medicare Physician Fee Schedule9
&
Medicare Part B payment10

CPT® 93303,93304, 93306,93307,9330811
&
Q99505

See Medicare Physician Fee Schedule9
Updated quarterly based on (ASP) + 6%12
Final payment determined by individual carriers

2016 REIMBURSEMENT INFORMATION: Ultrasonography of the Liver

Medicare Coding and Payment Overview:

Adult and Pediatric Ultrasonography of the liver for characterization of focal liver lesions1 with LUMASON®.

National Reimbursement Rates Shown

Procedure Setting

Reimbursement Policy

Codes

2016 National Average Reimbursement rates:

HOPPS (Hospital Outpatient Setting)

Medicare packages payment for contrast imaging agents into the payment for the associated procedure2

New! Effective Oct. 1, 2016
HCPCS code: C9744
Ultrasound, abdominal, with contrast13

(For commercial payers: verify if the C-code is applicable or if the CPT® codes: 76700 or 76705 should be used based on exam performed)

APC 5571:
C97445: $236.86

HOPPS Transitional Pass Through Code for LUMASON Only

Temporary additional HOPPS payment for innovative medical devices, drugs and biological for Medicare beneficiaries4. It is not subject to coinsurance or packaging rules.

Q99505

Updated quarterly based on Average Sales Price (ASP) + 6%5,6
Five mL per vial1

Hospital In-patient

Part of MS-DRG payment7

ICD-10-PCS8

No separate reimbursement for contrast agents7

Physician Office and Free Standing Imaging Centers

Medicare Physician Fee Schedule9
&
Medicare Part B payment10

CPT®76700 Ultrasound, abdominal, w/real-time documentation, complete14
Or:
CPT®76705 Ultrasound, abdominal, w/real-time documentation, limited14
&
Q99505

$124.249 (global)
$92.739 (global)
Updated quarterly based on ASP + 6%12
Final payment determined by individual carriers

Ultrasonography of the Liver: New! Effective October 1st, 2016:

Global, Professional and Technical Component Information15

 

CEUS Technical Component

CEUS Professional Component

CEUS Global

Contrast Agent

Hospital in-patient

MS-DRG

76705-26

 

Q9950

Hospital outpatient

C9744

76705-26

 

Q9950

Office/Free Standing Imaging Center

76705-TC

76705-26

76705

Q9950

C9744 is effective since October 1, 2016. C codes are unique temporary pricing codes established by CMS, and apply only to the hospital outpatient setting. Per CMS, the C codes (PassThrough) were established to permit implementation of section 201 of the Balanced Budget Refinement Act of 1999. HCPCS C codes are utilized to report drugs, biologicals, magnetic resonance angiography (MRA) and devices that must be used by OPPS hospitals. HCPCS C codes are reported for device categories, new technology procedures, and drugs, biologicals and radiopharmaceuticals that do not have other HCPCS code assignments.

Q9950: Hospital Outpatient Prospective Payment System transition Pass Through code for LUMASON® only through December 31, 2017: for quarterly reimbursement value:https://www.cms.gov/Medicare/Medicare-Fee-For-Service-Payment/HospitalOutpatientpps/Addendum-A-and-Addendum-B-Updates.html.
For the office/ free standing imaging center, refer to Medicare Part B Drug ASP file updated quarterly: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/2016ASPFiles.html. For the hospital in-patient setting, you may report revenue code 25X.

Code 96374, Therapeutic, prophylactic or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug reimbursed if the physician provider bills from a place of service 11 (office).

References:
References Accessed October 2016
1.1. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use full Prescribing Information. Monroe Township, NJ: Bracco Diagnostics Inc., December 2016.
2.https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnmattersarticles/downloads/mm8338.pdf
3.https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/Hospital-Outpatient-Regulations-and-Notices-Items/CMS-1633-FC.html?DLPage=1&DLEntries=10&DLSort=2&DLSortDir=descending
4.https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/HospitalOutpaysysfctsht.pdf
5.https://www.cms.gov/Medicare/Medicare-Fee-For-Service-Payment/HospitalOutpatientpps/Addendum-A-and-Addendum-B-Updates.html
6.https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c17.pdf
7.http://health-information.advanceweb.com/Web-Extras/CCS-Prep/An-Inpatient-Prospective-Payment-System-Refresher-MS-DRGs-2.aspx
8.https://www.cms.gov/Medicare/Coding/ICD10/Downloads/ICD-10Overview.pdf
9.https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PFSlookup/index.html
10.https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/Radiology_FactSheet_ICN907164.pdf
11. American Medical Association. 2016 Professional Edition CPT® current procedural terminology. Chicago, IL: American Medical Association; 2015: p. 611-612.
12https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/2016ASPFiles.html
13.https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9768.pdf
14. American Medical Association. 2016 Professional Edition CPT® current procedural terminology. Chicago, IL: American Medical Association; 2015: p. 448-449.
15.http://www.acr.org/Advocacy/eNews/20160930-Issue/CMS-to-Update-Contrast-Ultrasound-Billing-Code

Find Your Rep

Enter your ZIP code in the box below:

Lumason® Images

Echocardiography images shown are representative images from reference studies. Individual results may vary.

INDICATIONS AND USAGE 1
LUMASON is an ultrasound contrast agent indicated for use:

  • in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms
  • in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients
  • in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients

CONTRAINDICATIONS 1
LUMASON is contraindicated in patients with:

  • history of hypersensitivity reactions to sulfur hexafluoride lipid microsphere components or to any of the inactive ingredients in LUMASON.

IMPORTANT SAFETY INFORMATION1

WARNING: SERIOUS CARDIOPULMONARY REACTIONS

Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following the injection of ultrasound contrast agents, including sulfur hexafluoride lipid microspheres [see Warnings and Precautions (5.1)]. Most serious reactions occur within 30 minutes of administration [see Warnings and Precautions (5.1)].

  • Assess all patients for the presence of any condition that precludes administration [see Contraindications (4)].
  • Always have resuscitation equipment and trained personnel readily available [see Warnings and Precautions (5.1)].

The risk for serious cardiopulmonary reactions may be increased among patients with unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias) [see Warnings and Precautions (5.1)].1

Please see full Prescribing Information including Boxed Warning contained within this website.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

LUMASON is manufactured for Bracco Diagnostics Inc., Monroe Township, NJ 08831 by Bracco Suisse SA, Plan-les-Ouates Geneve, Switzerland (LUMASON lyophilized powder vial-25 mg lipid-type A/60.7 sulfur hexafluoride gas); Vetter Pharma-Fertigung GmbH & Co. KG, 88212 Ravensburg, Germany (Sodium Chloride 0.9% Injection, USP); B. Braun Melsungen AG, 34212 Melsungen, Germany (Mini-Spike).

LUMASON is a registered trademark of Bracco Diagnostics Inc.
SonoVue is a registered trademark of Bracco Suisse SA.

Bracco Diagnostics Inc.
259 Prospect Plains Road, Building H
Monroe Township, NJ 08831 USA
Phone: 609-514-2200
Toll Free: 1-877-272-2269 (U.S. only)
Fax: 609-514-2446

©2016 Bracco Diagnostics Inc. All Rights Reserved.